Welcome to Cleveland Clinic Online Health Chats

Get answers to your health questions and concerns. It's easy to be part of our live chat events, led by Cleveland Clinic physicians and health professionals.

Coronary Artery Disease (CAD) - Medical and Surgical Options
Thursday, July 17, 2014 - 12 Noon (Eastern Time)

Sign up for this chat today.Register Now

Click Join Chat to join the chat in progress.You will be asked to login if you aren't already logged in.Join Chat

Stephen Ellis, MD

  • Section Head of Invasive/Interventional Cardiology
  • Sydell and Arnold Miller Family Heart & Vascular Institute

Stephanie Mick, MD

  • Cardiovascular Surgeon
  • Sydell and Arnold Miller Family Heart & Vascular Institute

Coronary artery disease (CAD) is the most common type of heart disease and is the leading cause of death in the United States for both men and women. CAD is the narrowing or blockage of the coronary arteries, usually caused by atherosclerosis. Atherosclerosis is the buildup of cholesterol and fatty deposits (plaque) on the inner walls of the arteries, which can restrict blood flow to the heart muscle by physically clogging the artery or by causing abnormal artery tone and function. Without an adequate blood supply, the heart becomes starved of oxygen and the vital nutrients it needs to work properly. The most common symptom of coronary artery disease is angina, often referred to as chest pain. Treatment for coronary artery disease involves reducing your risk factors, taking medications, possibly undergoing invasive and/or surgical procedures and seeing your doctor for regular visits. Treating coronary artery disease is important to reduce your risk of heart attack or stroke. Take advantage of this opportunity to have your questions answered by cardiologist Stephen Ellis, MD and cardiovascular surgeon Stephanie Mick, MD from Cleveland Clinic’s Heart and Vascular Institute.

Stephen Ellis, MD is the Section Head of Invasive/Interventional Cardiology in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at the Sydell and Arnold Miller Family Heart & Vascular Institute. He also is co-director and co-founder of the Cardiovascular Genebank.

His principal clinical interests are complex coronary interventions, novel treatments for inoperable patients, minimally invasive treatments for aortic valve diseases and studies to better understand the basis and predict the occurrence of disease (genomics and proteomics).

Dr. Ellis is board-certified in Internal Medicine, Cardiology and Interventional Cardiology and is a member of the American Heart Association's Scientific Council on Arteriosclerosis and Scientific Council on Clinical Cardiology.

He has also served as the principal investigator for numerous national and international clinical studies that have changed the approach to treatment of coronary artery disease, including the RESCUE I trial, GUSTO IIb PTCA study, TAXUS IV and V trials, the FINESSE trial and the ABSORB III and IV trials.

Stephanie Mick, MD, is a cardiovascular surgeon in the Department of Thoracic and Cardiovascular Surgery in the Sydell and Arnold Miller Family Heart & Vascular Institute. She is board-certified in cardiothoracic surgery and has a special interest in minimally invasive and robotic cardiac surgery as well as complex cardiac surgery in adults.

Dr. Mick is involved in several significant clinical research projects at Cleveland Clinic, including studies on rare complications following heart attack, trends in the surgical treatment of endocarditis (inflammation of the heart lining and valves) and robotic and minimally invasive surgery.

She has authored more than two dozen articles and editorials published in leading medical journals and has been an invited presenter at meetings of the American Heart Association, the New York Academy of Sciences and the American Academy of Cardiovascular Perfusion. Dr. Mick is a member of the American Heart Association, American College of Surgeons, American Medical Association and Society of Thoracic Surgeons.

This Health Chat is currently open to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.